Delhi HC Directs Centre to Release 14 Crores to Panacea Biotech for Manufacturing Vaccine - 07.06.2021

Delhi High Court has directed the Centre to release an amount of Rs. 14 Crores along with the interest of 12% to Panacea Biotech for manufacturing Sputnik V subject to the condition of receiving permission from respective authorities to manufacture it in India.

Tags : Delhi High Court Panacea Biotech Manufacturing of Sputnik V Vaccine

Share :